News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Schwarz Pharma Has Approvable FDA Letter For Neupro


3/1/2006 10:26:16 AM

FRANKFURT, March 1 (Reuters) - Schwarz Pharma's (SRZG.DE: Quote, Profile, Research) Neupro drug for the treatment of early Parkinson's disease has won an approvable letter from the U.S. Food and Drug Administration (FDA), the German company said on Wednesday.

Read at Reuters
Read at Dow Jones

comments powered by Disqus
Reuters
Dow Jones
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES